Dupilumab Subcutaneous and Lantus SoloStar
Determining the interaction of Dupilumab Subcutaneous and Lantus SoloStar and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Lantus Solostar Pen
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Lantus SoloStar (Insulin Glargine (U-100) Cartridge Systems and Pens)
- Dupilumab Subcutaneous-Lantus Solostar (Insulin Glargine (U-300) Pens)
- Dupilumab Subcutaneous-Lantus Solostar Pen
- Dupilumab Subcutaneous-Lapatinib
- Dupilumab Subcutaneous-Lapatinib Ditosylate
- Dupilumab Subcutaneous-Lariam
- Lantus SoloStar-Dupixent
- Lantus SoloStar-Duplex T Topical
- Lantus SoloStar-Durachol
- Lantus SoloStar-Duraclon
- Lantus SoloStar-Duraclon injection
- Lantus SoloStar-Duraflu